Brief: aap Implantate Q2 EBITDA loss widens to 1.6 million euros

aap Implantate AG

14/08/2017 07:25

Aug 14 (Reuters) - AAP IMPLANTATE AG  AAQG.DE : 
    * Q2 SALES AND EBITDA IN LINE WITH GUIDANCE; 14% SALES 
GROWTH IN TRAUMA IN H1/2017 
    * SALES: TRAUMA SALES UP BY 14% ON A HALF YEAR BASIS TO EUR 
5.2 MILLION (H1/2016 LIKE-FOR-LIKE: EUR 4.5 MILLION) 
    * EBITDA IN Q2 OF 2017 OF EUR -1.6 MILLION (Q2/2016: EUR 
-1.4 MILLION) 
    * FOR Q3 OF 2017 AAP ANTICIPATES SALES OF EUR 1.8 MILLION 
TO EUR 3.0 MILLION AND AN EBITDA OF EUR -1.8 MILLION TO EUR -1.2 
MILLION 
    * IN Q2 OF 2017 SALES WERE DOWN 12% FROM EUR 2.7 MILLION TO 
EUR 2.3 MILLION 
 
Source text for Eikon:  ID:nEQ68Ncmha  
Further company coverage:  AAQG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))